Screener
Intellia Therapeutics NTLA Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Intellia Therapeutics’s reported figures.
The source filing: Intellia Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337952
FAQ
- What is Intellia Therapeutics's free cash flow?
- Intellia Therapeutics (NTLA) reported free cash flow of -$84.92M in Q2 2026.
- How has Intellia Therapeutics's free cash flow changed year-over-year?
- Intellia Therapeutics's free cash flow increased by 15.0% year-over-year, from -$99.86M to -$84.92M.
- What is the long-term trend for Intellia Therapeutics's free cash flow?
- Over 4 years (2021 to 2025), Intellia Therapeutics's free cash flow has grown at a 13.6% compound annual growth rate (CAGR), from -$237.79M to -$395.87M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Intellia Therapeutics's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude